Curi RMB Capital LLC Has $9.08 Million Stock Position in Abacus Life, Inc. (NASDAQ:ABL)

Curi RMB Capital LLC lifted its holdings in Abacus Life, Inc. (NASDAQ:ABL - Free Report) by 110.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,159,000 shares of the company's stock after acquiring an additional 609,000 shares during the period. Curi RMB Capital LLC owned approximately 1.20% of Abacus Life worth $9,075,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Marshall Wace LLP bought a new position in shares of Abacus Life in the fourth quarter worth $1,293,000. XTX Topco Ltd acquired a new position in shares of Abacus Life in the 4th quarter valued at approximately $193,000. Kennedy Capital Management LLC bought a new stake in shares of Abacus Life during the 4th quarter worth approximately $7,461,000. Renaissance Technologies LLC boosted its position in shares of Abacus Life by 356.0% during the 4th quarter. Renaissance Technologies LLC now owns 210,500 shares of the company's stock worth $1,648,000 after acquiring an additional 164,334 shares in the last quarter. Finally, Foundry Partners LLC bought a new position in Abacus Life in the fourth quarter valued at approximately $5,364,000.

Abacus Life Trading Down 0.4 %

NASDAQ ABL traded down $0.04 on Friday, hitting $8.26. The company's stock had a trading volume of 71,350 shares, compared to its average volume of 175,439. The company's 50-day moving average is $7.57 and its 200 day moving average is $7.96. The firm has a market cap of $800.39 million, a PE ratio of -45.83 and a beta of 0.16. Abacus Life, Inc. has a 1-year low of $6.34 and a 1-year high of $12.45. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65.

Abacus Life (NASDAQ:ABL - Get Free Report) last announced its earnings results on Thursday, March 27th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.03. The business had revenue of $33.21 million during the quarter, compared to analyst estimates of $28.76 million. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. As a group, analysts predict that Abacus Life, Inc. will post 0.62 earnings per share for the current fiscal year.

Analyst Ratings Changes

ABL has been the topic of several recent analyst reports. Piper Sandler decreased their price target on Abacus Life from $13.00 to $11.50 and set an "overweight" rating on the stock in a research note on Tuesday, April 8th. B. Riley lowered their target price on Abacus Life from $17.00 to $15.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $14.00.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.